- Home
- COOK vs GHRS Comparison
COOK vs GHRS Comparison
Compare COOK & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- GHRS
- Stock Information
- Founded
- COOK 1985
- GHRS 2018
- Country
- COOK United States
- GHRS Ireland
- Employees
- COOK N/A
- GHRS N/A
- Industry
- COOK Wholesale Distributors
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- GHRS Health Care
- Exchange
- COOK Nasdaq
- GHRS Nasdaq
- Market Cap
- COOK 406.5M
- GHRS 402.7M
- IPO Year
- COOK 2021
- GHRS 2021
- Fundamental
- Price
- COOK $2.98
- GHRS $8.13
- Analyst Decision
- COOK Buy
- GHRS Strong Buy
- Analyst Count
- COOK 6
- GHRS 3
- Target Price
- COOK $4.00
- GHRS $35.67
- AVG Volume (30 Days)
- COOK 164.1K
- GHRS 55.0K
- Earning Date
- COOK 11-06-2024
- GHRS 11-14-2024
- Dividend Yield
- COOK N/A
- GHRS N/A
- EPS Growth
- COOK N/A
- GHRS N/A
- EPS
- COOK N/A
- GHRS N/A
- Revenue
- COOK $598,914,000.00
- GHRS N/A
- Revenue This Year
- COOK $1.02
- GHRS N/A
- Revenue Next Year
- COOK $4.69
- GHRS N/A
- P/E Ratio
- COOK N/A
- GHRS N/A
- Revenue Growth
- COOK 3.17
- GHRS N/A
- 52 Week Low
- COOK $1.97
- GHRS $5.08
- 52 Week High
- COOK $3.97
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- COOK 41.52
- GHRS 45.97
- Support Level
- COOK $2.94
- GHRS $7.29
- Resistance Level
- COOK $3.31
- GHRS $8.91
- Average True Range (ATR)
- COOK 0.14
- GHRS 0.79
- MACD
- COOK -0.02
- GHRS -0.08
- Stochastic Oscillator
- COOK 8.16
- GHRS 31.55
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.